Protalix BioTherapeutics Inc (PLX)
1.11
-0.03
(-2.63%)
USD |
NYAM |
May 06, 16:00
1.115
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Accounts Payable (Quarterly): 4.32M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.32M |
September 30, 2023 | 3.114M |
June 30, 2023 | 3.304M |
March 31, 2023 | 5.105M |
December 31, 2022 | 5.862M |
September 30, 2022 | 5.639M |
June 30, 2022 | 6.991M |
March 31, 2022 | 7.873M |
December 31, 2021 | 6.986M |
September 30, 2021 | 8.436M |
June 30, 2021 | 6.128M |
March 31, 2021 | 6.376M |
December 31, 2020 | 7.221M |
September 30, 2020 | 8.351M |
June 30, 2020 | 6.707M |
March 31, 2020 | 9.43M |
December 31, 2019 | 6.495M |
September 30, 2019 | 7.755M |
June 30, 2019 | 6.728M |
March 31, 2019 | 5.87M |
December 31, 2018 | 5.211M |
September 30, 2018 | 4.388M |
June 30, 2018 | 6.001M |
March 31, 2018 | 4.872M |
December 31, 2017 | 7.521M |
Date | Value |
---|---|
September 30, 2017 | 8.691M |
June 30, 2017 | 7.852M |
March 31, 2017 | 5.999M |
December 31, 2016 | 4.007M |
September 30, 2016 | 3.989M |
June 30, 2016 | 3.819M |
March 31, 2016 | 3.89M |
December 31, 2015 | 3.629M |
September 30, 2015 | 4.057M |
June 30, 2015 | 4.275M |
March 31, 2015 | 5.195M |
December 31, 2014 | 3.836M |
September 30, 2014 | 3.578M |
June 30, 2014 | 3.592M |
March 31, 2014 | 4.639M |
December 31, 2013 | 5.254M |
September 30, 2013 | 3.313M |
June 30, 2013 | 3.944M |
March 31, 2013 | 3.762M |
December 31, 2012 | 5.267M |
September 30, 2012 | 4.427M |
June 30, 2012 | 4.512M |
March 31, 2012 | 4.568M |
December 31, 2011 | 5.032M |
September 30, 2011 | 12.68M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.114M
Minimum
Sep 2023
9.43M
Maximum
Mar 2020
6.464M
Average
6.707M
Median
Jun 2020
Accounts Payable (Quarterly) Benchmarks
Agenus Inc | 61.45M |
InfuSystems Holdings Inc | 8.009M |
AIM ImmunoTech Inc | 6.443M |
Perspective Therapeutics Inc | 6.107M |
Armata Pharmaceuticals Inc | 1.585M |